We are live on ! Find out more
QTTB icon

Q32 Bio

86 hedge funds and large institutions have $756M invested in Q32 Bio in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 8

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

33% more capital invested

Capital invested by funds: $569M → $756M (+$187M)

23% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 22

8% more funds holding

Funds holding: 8086 (+6)

0.64% more ownership

Funds ownership: 3.97%4.61% (+0.64%)

97% less call options, than puts

Call options by funds: $28K | Put options by funds: $924K

Holders
86
Holders Change
+6
Holders Change %
+7.5%
% of All Funds
1.69%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.08%
New
19
Increased
27
Reduced
22
Closed
8
Calls
$28K
Puts
$924K
Net Calls
-$896K
Net Calls Change
-$920K
Name Holding Trade Value Shares
Change
Change in
Stake
HAM
26
HHR Asset Management
New Jersey
$1.6M -$123K -428 -9%
Balyasny Asset Management
27
Balyasny Asset Management
Illinois
$1.48M +$1.13M +3,958 New
TD Asset Management
28
TD Asset Management
Ontario, Canada
$1.35M -$43.2K -151 -4%
SI
29
Sofinnova Investments
California
$1.33M -$1.3M -4,550 -56%
Russell Investments Group
30
Russell Investments Group
United Kingdom
$1.23M
Millennium Management
31
Millennium Management
New York
$1.18M +$905K +3,159 New
VOYA Investment Management
32
VOYA Investment Management
Georgia
$1.09M -$216K -755 -21%
Goldman Sachs
33
Goldman Sachs
New York
$1.05M +$214K +747 +36%
SAM
34
Sectoral Asset Management
Quebec, Canada
$904K -$488K -1,705 -41%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$845K +$460K +1,607 +243%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$800K
Swiss National Bank
37
Swiss National Bank
Switzerland
$785K +$27.2K +95 +5%
Morgan Stanley
38
Morgan Stanley
New York
$757K +$432K +1,509 +289%
State of Wisconsin Investment Board
39
State of Wisconsin Investment Board
Wisconsin
$756K
WG
40
Winton Group
United Kingdom
$731K +$562K +1,962 New
PPA
41
Parametric Portfolio Associates
Washington
$655K +$67.6K +236 +16%
Squarepoint
42
Squarepoint
New York
$608K +$467K +1,631 New
AllianceBernstein
43
AllianceBernstein
Tennessee
$598K +$33.5K +117 +8%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$596K +$4.58K +16 +1%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$569K +$212K +739 +94%
Barclays
46
Barclays
United Kingdom
$550K +$182K +634 +75%
Wells Fargo
47
Wells Fargo
California
$542K +$147K +512 +54%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$518K
ARTA
49
A.R.T. Advisors
New York
$505K +$388K +1,355 New
Citadel Advisors
50
Citadel Advisors
Florida
$484K -$11.3M -39,430 -97%

QTTB Hedge Fund Activity: Q4 2019 in Review

86 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2019, worth a combined $756M — up 33% from $569M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new QTTB positions and 8 closed out — a net gain of 11 holders — while 27 added to existing stakes and 22 trimmed.

The largest buyer was RTW Investments, adding an estimated $30.2M. The largest seller was Casdin Capital, exiting entirely with an estimated $14.8M sold.

  • 86 institutional investors held Q32 Bio (QTTB) as of Q4 2019, up from 80 in Q3 2019.
  • Funds reported $756M of Q32 Bio stock for Q4 2019, up 33% quarter-over-quarter.
  • 19 funds opened new Q32 Bio positions in Q4 2019 and 8 closed out, a net change of +11 holders.
  • The largest Q32 Bio buyer in Q4 2019 was RTW Investments, an estimated $30.2M added.
  • The largest Q32 Bio seller in Q4 2019 was Casdin Capital, an estimated $14.8M sold.

Based on aggregated 13F filings for Q4 2019.